CVS Health (CVS) reachead $62.92 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close.
The market speculates that following the FTC notice, several investors are pushing CVS Health to go for segment breakups.
In the high-stakes world of healthcare retail, CVS Health finds itself at a crossroads, navigating turbulent waters amid investor pressures and a stock price that seems to be on a downward spiral. As the pharmacy giant embarks on a strategic review, including possibly splitting its insurance and retail arms, CEO Karen S.
CVS Health (CVS) shares have been in the spotlight following reports that the healthcare services giant is considering separating its retail pharmacy and insurance units as it looks to improve profitability and appease investors.
In September, US companies increased hiring activity, ending a five-month slowdown in employment growth. Data from the ADP report, often called "mini non-farm payrolls," showed an increase of 143,000 jobs, surpassing economists' expectations of 125,000, while August saw the smallest gain since March 2023.
CVS Health stock (NYSE: CVS) currently trades at $65 per share, 37% below its pre-inflation shock high of $102 seen in February 2022. In contrast, its peer – Walgreens stock – is down 78% over this period, amid falling profitability.
Splitting up the company would face challenges, but there is no perfect solution to its struggles.
Glenview Capital Management, a hudge fund that has been subject of certain media reports that it was pushing CVS Health management to break up the healthcare giant, denies it is “pushing for a break-up.”
CVS plans to lay off 2,900 workers, the company announced this week. The move comes as the pharmacy has been struggling with costs in a tough economy, and is considering breaking the company into two separate businesses, as Reuters reported.
“While there's no guarantee it will happen, any company split would acknowledge that CVS can't be the integrated healthcare powerhouse it once thought,” one analyst said.
Health conglomerate CVS Health said on Tuesday it will lay off about 2,900 employees, as it aims to cut costs.
The job cuts will not affect front-line jobs in CVS stores, pharmacies or distribution centers, a spokesperson said.